A detailed history of Grandfield & Dodd, LLC transactions in Sanofi stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 386,491 shares of SNY stock, worth $19.6 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares
386,491
Previous 381,978 1.18%
Holding current value
$19.6 Million
Previous $19 Million 1.12%
% of portfolio
1.25%
Previous 1.38%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$45.75 - $52.48 $206,469 - $236,842
4,513 Added 1.18%
386,491 $18.8 Million
Q4 2023

Jan 31, 2024

BUY
$43.13 - $54.79 $241,528 - $306,824
5,600 Added 1.49%
381,978 $19 Million
Q3 2023

Oct 25, 2023

BUY
$50.95 - $55.2 $257,552 - $279,036
5,055 Added 1.36%
376,378 $20.2 Million
Q2 2023

Aug 07, 2023

SELL
$50.45 - $57.18 $96,662 - $109,556
-1,916 Reduced 0.51%
371,323 $20 Million
Q1 2023

Apr 28, 2023

BUY
$45.86 - $54.45 $247,414 - $293,757
5,395 Added 1.47%
373,239 $20.3 Million
Q4 2022

Jan 20, 2023

BUY
$38.86 - $48.55 $1.08 Million - $1.36 Million
27,918 Added 8.21%
367,844 $0
Q3 2022

Nov 03, 2022

BUY
$37.22 - $100.5 $49,353 - $133,263
1,326 Added 0.39%
339,926 $12.9 Million
Q2 2022

Aug 01, 2022

BUY
$48.99 - $57.46 $24,984 - $29,304
510 Added 0.15%
338,600 $16.9 Million
Q1 2022

Apr 19, 2022

BUY
$48.48 - $53.65 $150,288 - $166,315
3,100 Added 0.93%
338,090 $17.4 Million
Q4 2021

Feb 08, 2022

BUY
$47.07 - $52.35 $328,360 - $365,193
6,976 Added 2.13%
334,990 $16.8 Million
Q3 2021

Oct 28, 2021

BUY
$47.89 - $53.12 $238,348 - $264,378
4,977 Added 1.54%
328,014 $15.8 Million
Q2 2021

Jul 28, 2021

BUY
$49.36 - $54.25 $354,158 - $389,243
7,175 Added 2.27%
323,037 $17 Million
Q1 2021

Apr 22, 2021

BUY
$45.46 - $50.51 $132,652 - $147,388
2,918 Added 0.93%
315,862 $15.6 Million
Q4 2020

Jan 29, 2021

BUY
$45.3 - $51.62 $402,490 - $458,643
8,885 Added 2.92%
312,944 $15.2 Million
Q3 2020

Nov 03, 2020

BUY
$49.47 - $53.77 $77,173 - $83,881
1,560 Added 0.52%
304,059 $15.3 Million
Q2 2020

Jul 24, 2020

SELL
$42.91 - $52.5 $12.9 Million - $15.8 Million
-301,164 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$38.02 - $51.66 $15,208 - $20,664
-400 Reduced 0.13%
301,164 $13.2 Million
Q4 2019

Feb 07, 2020

BUY
$44.25 - $50.86 $346,256 - $397,979
7,825 Added 2.66%
301,564 $15.1 Million
Q3 2019

Oct 30, 2019

BUY
$40.34 - $46.64 $8,068 - $9,328
200 Added 0.07%
293,739 $13.6 Million
Q2 2019

Jul 29, 2019

BUY
$40.43 - $44.3 $398,235 - $436,355
9,850 Added 3.47%
293,539 $12.7 Million
Q1 2019

Apr 26, 2019

SELL
$40.83 - $45.43 $84,722 - $94,267
-2,075 Reduced 0.73%
283,689 $12.6 Million
Q4 2018

Feb 12, 2019

BUY
$41.48 - $45.59 $94,989 - $104,401
2,290 Added 0.81%
285,764 $12.4 Million
Q3 2018

Nov 02, 2018

BUY
$40.0 - $44.84 $233,600 - $261,865
5,840 Added 2.1%
283,474 $12.7 Million
Q2 2018

Jul 27, 2018

BUY
$37.63 - $41.22 $405,839 - $444,557
10,785 Added 4.04%
277,634 $11.1 Million
Q1 2018

May 04, 2018

BUY
$38.98 - $45.76 $615,884 - $723,008
15,800 Added 6.29%
266,849 $10.7 Million
Q4 2017

Feb 06, 2018

BUY
$42.86 - $50.61 $195,441 - $230,781
4,560 Added 1.85%
251,049 $10.8 Million
Q3 2017

Nov 03, 2017

BUY
$47.04 - $50.34 $11.6 Million - $12.4 Million
246,489
246,489 $12.3 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $127B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Grandfield & Dodd, LLC Portfolio

Follow Grandfield & Dodd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.